Citation
Kawashima, H, et al. "[Acute Mixed Lineage Leukemia Showing Resistance to AML and ALL Therapy]." [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology, vol. 34, no. 5, 1993, pp. 643-8.
Kawashima H, Iizuka Y, Kondou W, et al. [Acute mixed lineage leukemia showing resistance to AML and ALL therapy]. Rinsho Ketsueki. 1993;34(5):643-8.
Kawashima, H., Iizuka, Y., Kondou, W., Hirota, H., Okuyama, Y., Kanou, M., Ichii, S., Murakami, J., Tsuchiya, T., & Sawada, T. (1993). [Acute mixed lineage leukemia showing resistance to AML and ALL therapy]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology, 34(5), 643-8.
Kawashima H, et al. [Acute Mixed Lineage Leukemia Showing Resistance to AML and ALL Therapy]. Rinsho Ketsueki. 1993;34(5):643-8. PubMed PMID: 7686236.
TY - JOUR
T1 - [Acute mixed lineage leukemia showing resistance to AML and ALL therapy].
A1 - Kawashima,H,
AU - Iizuka,Y,
AU - Kondou,W,
AU - Hirota,H,
AU - Okuyama,Y,
AU - Kanou,M,
AU - Ichii,S,
AU - Murakami,J,
AU - Tsuchiya,T,
AU - Sawada,T,
PY - 1993/5/1/pubmed
PY - 1993/5/1/medline
PY - 1993/5/1/entrez
SP - 643
EP - 8
JF - [Rinsho ketsueki] The Japanese journal of clinical hematology
JO - Rinsho Ketsueki
VL - 34
IS - 5
N2 - A 51-year-old female was who admitted complaining of cough and slight fever and lower limb petechia. The laboratory examinations revealed leukocytosis (49,400/microliters) with blasts (71%) in the peripheral blood. The NCC was 30 x 10(4)/microliters with 84.8% blasts in the bone marrow. Myeloperoxidase staining was positive for 6% of blasts. Auer rods were not seen in some blasts. Thus, acute myeloblastic leukemia (M1) was diagnosed according to FAB classification. In the peripheral blood, 43.3% of blasts expressed CD19, 10.3% of blasts expressed CD20 and 55.6% of blasts expressed CD33 on admission. Though she received two courses of DCMP according to the DCMP-85 protocol, and one combined course of mitoxantrone, etoposide, and Ara-C. The NCC was 20.0 x 10(4)/microliters with 70% blasts in the bone marrow. CD19 was expressed by 72.4% of blasts and 35.0% expressed CD20. The ALL-90 protocol was started, but remission was not achieved. Thus this case was considered to be acute mixed lineage leukemia.
SN - 0485-1439
UR - https://www.unboundmedicine.com/medline/citation/7686236/[Acute_mixed_lineage_leukemia_showing_resistance_to_AML_and_ALL_therapy]_
DB - PRIME
DP - Unbound Medicine
ER -